5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide
-
![5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/cc9f01038f564cf0bee20888320b6b3a.png "5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide")
5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide
structure -
-
CAS No:
107188-66-9
-
Formula:
C16H23BrN2O3
-
Chemical Name:
5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide
-
Synonyms:
5-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,3-dimethoxybenzamide;cyclopropyl-FLB 457;FLB 457;FLB 457, (R)-isomer;FLB 457, (S)-isomer;FLB 457, hydrobromide, (R)-isomer;FLB 457, hydrobromide, (S)-isomer;FLB-457;107188-66-9;5-Bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,3-dimethoxybenzamide;5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide;5-bromo-N-((1-ethylpyrrolidin-2-yl)methyl)-2,3-dimethoxybenzamide;ACMC-20maw0;ACMC-20maw1;CHEMBL311839;Benzamide,5-bromo-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2,3-dimethoxy-;SCHEMBL10355542;DTXSID70910248;Benzamide,5-bromo-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,3-dimethoxy-;FT-0772966;methyl?2-(4-(benzyloxy)phenyl)-4-oxobutanoate;L004158;5-Bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzene-1-carboximidic acid
- Categories:
-
CAS No:
5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide Basic Attributes
371.27 g/mol
370.08921 g/mol
Drug Information
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
5-bromo-N-((1-ethyl-2-pyrrolidinyl)methyl)-2,3-dimethoxybenzamide
Computed Properties
Molecular Weight:371.27
XLogP3:2.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:6
Exact Mass:370.08921
Monoisotopic Mass:370.08921
Topological Polar Surface Area:50.8
Heavy Atom Count:22
Complexity:369
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of 5-bromo-N-[(1-ethylpyrrolidin-2-yl)methyl]-2,3-dimethoxybenzamide
-
![China]()
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Active Pharm Ingredients,Chemical Catalyst,Pharmaceutical Intermediates,Flavors and Fragrances,Agrochemicals,Chemical Pesticides,Organic Intermediates,OLED IntermediatesInquiryCAS No.: 107188-66-9Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
10-Bromo-1-decanol
53463-68-6
-
Triclosan
3380-34-5
-
BOC-L-3-BENZOTHIENYLALANINE
154902-51-9
-
10-Chloro-1-decanol Formula
51309-10-5
-
2-(bromomethyl)-1-chloro-4-methoxybenzene Formula
3771-13-9
-
1,1,3-Tribromoacetone Formula
3475-39-6
-
Benzeneacetic acid, 3-methyl-, ethyl ester Structure
40061-55-0
-
2-BROMO-5-PHENYLPYRIDINE Structure
107351-82-6
-
What is 2,6-Diethylaniline
579-66-8
-
What is Ethyl 5-amino-4-cyano-3-(2-ethoxy-2-ox...
58168-20-0
Request for Quotation